RxDoctor Payments Data

John Stauffer, MD

Surgical Oncology · Jacksonville, FLNPI 1073752408

Payments from drug & device makers

What this record shows

9 manufacturers reported payments, led by Intuitive Surgical at 54.5% of the total. Reporting peaked in 2023 at $1,030 and has fallen 67.5% since, to $335 in 2024. That places this record below the midpoint for surgical oncology clinicians in FL, where the typical reported total is $1,867.

$2,328in general payments, 2019–2025

Across 23 payments — averaging $101.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Angiodynamics, Inc.$371
  • Boston Scientific$321
  • Ipsen Biopharmaceuticals, Inc$117
  • Olympus America Inc.$67
  • Varian Medical Systems, Inc.$62
  • plus $121 from 3 others
$21,991in research payments, 2019–2025

Across 6 payments — averaging $3665.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$22K

What the payments were for

  • Travel & lodging$98142%
  • Food & beverage$1,34758%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,328 in reported general payments places this provider in the 50th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$204,705
Medicare patients
168
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$60,034

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →